314 related articles for article (PubMed ID: 19120318)
41. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes.
Xanthis A; Hatzitolios A; Fidani S; Befani C; Giannakoulas G; Koliakos G
Angiology; 2009 Dec-2010 Jan; 60(6):772-9. PubMed ID: 19190027
[TBL] [Abstract][Full Text] [Related]
42. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
Rüster C; Bondeva T; Franke S; Förster M; Wolf G
Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
[TBL] [Abstract][Full Text] [Related]
43. Metformin prevents methylglyoxal-induced apoptosis of mouse Schwann cells.
Ota K; Nakamura J; Li W; Kozakae M; Watarai A; Nakamura N; Yasuda Y; Nakashima E; Naruse K; Watabe K; Kato K; Oiso Y; Hamada Y
Biochem Biophys Res Commun; 2007 May; 357(1):270-5. PubMed ID: 17418096
[TBL] [Abstract][Full Text] [Related]
44. MnTMPyP, a metalloporphyrin-based superoxide dismutase/catalase mimetic, protects INS-1 cells and human pancreatic islets from an in vitro oxidative challenge.
Moriscot C; Candel S; Sauret V; Kerr-Conte J; Richard MJ; Favrot MC; Benhamou PY
Diabetes Metab; 2007 Feb; 33(1):44-53. PubMed ID: 17258921
[TBL] [Abstract][Full Text] [Related]
45. AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation.
Gawlowski T; Stratmann B; Stirban AO; Negrean M; Tschoepe D
Thromb Res; 2007; 121(1):117-26. PubMed ID: 17445870
[TBL] [Abstract][Full Text] [Related]
46. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
Med Hypotheses; 2005; 64(6):1208-10. PubMed ID: 15823719
[TBL] [Abstract][Full Text] [Related]
47. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
Yan SF; Ramasamy R; Schmidt AM
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
[TBL] [Abstract][Full Text] [Related]
49. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
Wu L; Ma L; Nicholson LF; Black PN
Respir Med; 2011 Mar; 105(3):329-36. PubMed ID: 21112201
[TBL] [Abstract][Full Text] [Related]
50. Mechanistic study of endogenous skin lesions in diabetic rats.
Chen XF; Lin WD; Lu SL; Xie T; Ge K; Shi YQ; Zou JJ; Liu ZM; Liao WQ
Exp Dermatol; 2010 Dec; 19(12):1088-95. PubMed ID: 20701629
[TBL] [Abstract][Full Text] [Related]
51. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis.
Han SJ; Kang ES; Hur KY; Kim HJ; Kim SH; Yun CO; Choi SE; Ahn CW; Cha BS; Kang Y; Lee HC
Horm Res; 2008; 70(3):165-73. PubMed ID: 18663317
[TBL] [Abstract][Full Text] [Related]
52. Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways.
Li XL; Xu G; Chen T; Wong YS; Zhao HL; Fan RR; Gu XM; Tong PC; Chan JC
Int J Biochem Cell Biol; 2009 Jul; 41(7):1526-35. PubMed ID: 19166964
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
54. Triiodothyronine (T3)-mediated toxicity and induction of apoptosis in insulin-producing INS-1 cells.
Ximenes HM; Lortz S; Jörns A; Lenzen S
Life Sci; 2007 May; 80(22):2045-50. PubMed ID: 17408701
[TBL] [Abstract][Full Text] [Related]
55. Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Okuda S; Imaizumi T
Ophthalmic Res; 2008; 40(1):10-5. PubMed ID: 18025836
[TBL] [Abstract][Full Text] [Related]
56. Prohibitin is expressed in pancreatic beta-cells and protects against oxidative and proapoptotic effects of ethanol.
Lee JH; Nguyen KH; Mishra S; Nyomba BL
FEBS J; 2010 Jan; 277(2):488-500. PubMed ID: 20030709
[TBL] [Abstract][Full Text] [Related]
57. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
[TBL] [Abstract][Full Text] [Related]
58. TRIB3 [corrected] is implicated in glucotoxicity- and endoplasmic reticulum-stress-induced [corrected] beta-cell apoptosis.
Qian B; Wang H; Men X; Zhang W; Cai H; Xu S; Xu Y; Ye L; Wollheim CB; Lou J
J Endocrinol; 2008 Dec; 199(3):407-16. PubMed ID: 18818302
[TBL] [Abstract][Full Text] [Related]
59. ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells.
Alberti A; Karamessinis P; Peroulis M; Kypreou K; Kavvadas P; Pagakis S; Politis PK; Charonis A
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E812-21. PubMed ID: 19622788
[TBL] [Abstract][Full Text] [Related]
60. Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species.
Ko SY; Lin YP; Lin YS; Chang SS
Free Radic Biol Med; 2010 Aug; 49(3):474-80. PubMed ID: 20471471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
